<p>Coldstream Capital Management Inc. 在最近向美国证券交易委员会提交的 13F 文件中表示，在第四季度减少了对 Zoetis Inc.（纽约证券交易所代码：ZTS - 免费报告）股份的持有，减持幅度为 83.4%。该机构投资者在出售了 28,756 股后，持有该公司 5,727 股股票。根据其最近向美国证券交易委员会提交的文件，Coldstream Capital Management Inc. 在 Zoetis 的持股价值为 721,000 美元。</p>
<ul>
<li>2024 年哪只宠物股票值得关注？</li>
</ul>
<p>其他大型投资者最近也对该公司的持仓进行了调整。Global Wealth Strategies &amp; Associates 在第四季度购买了价值约 25,000 美元的 Zoetis 新股份。Lodestone Wealth Management LLC 在第四季度购买了价值约 30,000 美元的 Zoetis 新股份。KERR FINANCIAL PLANNING Corp 在第三季度购买了价值约 31,000 美元的 Zoetis 新股份。Holos Integrated Wealth LLC 在第四季度购买了价值约 32,000 美元的 Zoetis 新股份。最后，Elyxium Wealth LLC 在第四季度购买了价值约 32,000 美元的 Zoetis 新股份。机构投资者目前持有该公司 92.80% 的股份。</p>
<h2>内部活动</h2>
<p>在其他消息中，董事 Paul Bisaro 于 5 月 13 日星期三购买了 2,000 股该股票。每股平均成本为 75.88 美元，总交易额为 151,760.00 美元。交易完成后，该董事持有 27,862 股公司股票，价值约 2,114,168.56 美元。此交易代表其持仓增加了 7.73%。该交易已在美国证券交易委员会的法律文件中披露，相关信息可通过美国证券交易委员会网站获取。此外，董事 Frank A. Damelio 于 5 月 13 日星期三购买了 6,650 股该股票。每股购买价格为 75.39 美元，总交易额为 501,343.50 美元。交易完成后，该董事持有 21,458 股公司股票，价值 1,617,718.62 美元。此交易代表其持仓增加了 44.91%。有关此次购买的更多细节可在官方的美国证券交易委员会披露中找到。在过去的九十天里，内部人士购买了价值 886,384 美元的 11,650 股公司股票。公司内部人士持有该公司 0.22% 的股份。</p>
<h2>Zoetis 股票表现</h2>
<ul>
<li>MarketBeat 周回顾 – 07/31 - 08/04</li>
</ul>
<p>周四，ZTS 的开盘价为 79.48 美元。该股票的市值为 333.2 亿美元，市盈率为 13.18，市盈增长比率为 1.31，贝塔值为 0.87。该公司的流动比率为 3.15，速动比率为 1.91，债务与股本比率为 2.80。Zoetis Inc. 的一年低点为 72.38 美元，一年高点为 172.23 美元。该股票的 50 日简单移动平均为 105.95 美元，200 日简单移动平均为 117.60 美元。</p>
<p>Zoetis（纽约证券交易所代码：ZTS - 获取免费报告）最近于 5 月 7 日星期四发布了季度财报。该公司报告的每股收益（EPS）为 1.53 美元，低于分析师一致预期的 1.60 美元，差距为 0.07 美元。该公司季度收入为 22.6 亿美元，而一致预期为 23 亿美元。Zoetis 的净利润率为 27.80%，股本回报率为 66.85%。该公司季度收入同比增长 2.9%。在去年同期，该公司每股收益为 1.48 美元。Zoetis 已将其 2026 财年的指导目标设定为 6.850-7.000 每股收益。卖方分析师预测 Zoetis Inc. 本年度将发布 6.88 每股收益。</p>
<h2>Zoetis 宣布分红</h2>
<ul>
<li>不断上升的分红使 Zoetis 成为赢家</li>
</ul>
<p>该公司最近还披露了季度分红，将于 9 月 1 日星期二支付。7 月 20 日星期一的股东将获得每股 0.53 美元的分红。除息日期为 7 月 20 日星期一。这相当于每年 2.12 美元的分红，分红收益率为 2.7%。Zoetis 的派息比率目前为 35.16%。</p>
<h2>分析师评级变动</h2>
<p>几家券商最近对 ZTS 进行了评估。摩根大通将 Zoetis 的目标价从 190.00 美元下调至 130.00 美元，并在 5 月 8 日的研究报告中给予该公司 “增持” 评级。Argus 在周三的研究报告中重申了对 Zoetis 股票的 “持有” 评级。Weiss Ratings 将 Zoetis 的评级从 “持有（c-）” 下调至 “卖出（d+）”，该评级在 3 月 27 日的研究报告中发布。Wall Street Zen 在 5 月 2 日的研究报告中将 Zoetis 的评级从 “买入” 下调至 “持有”。最后，美国银行在 2 月 13 日的研究报告中将 Zoetis 的目标价从 135.00 美元上调至 140.00 美元，并给予该公司 “中性” 评级。六位分析师对该股票给予了买入评级，八位分析师给予了持有评级，一位分析师给予了卖出评级。根据 MarketBeat，Zoetis 目前的平均评级为 “持有”，平均目标价为 133.92 美元。</p>
<p><strong>阅读我们关于 ZTS 的最新报告</strong></p>
<h2>Zoetis 公司简介</h2>
<p>（免费报告）</p>
<p>Zoetis Inc.（纽约证券交易所代码：ZTS）是一家全球动物健康公司，开发、生产和销售广泛的宠物和牲畜产品及服务。该公司的产品包括药品、疫苗和生物制品、驱虫剂和抗感染药物，以及诊断仪器、耗材和实验室检测服务。Zoetis 为兽医社区、牲畜生产者和其他动物健康客户提供旨在预防、检测和治疗疾病的产品，以支持动物的生产力和福利。</p>
<p>Zoetis 的根源可以追溯到辉瑞的动物健康业务，并在 2013 年分拆和首次公开募股后成为一家独立的上市公司。</p>
<h2>推荐故事</h2>
<ul>
<li>五只我们认为比 Zoetis 更好的股票</li>
<li>Abercrombie 强劲的第一季度财报延续了胜利的势头</li>
<li>TeraWulf 投资电力基础设施以引领人工智能建设</li>
<li>亚马逊的 Alexa 购物功能增强了已经强劲的牛市论点</li>
<li>Keysight：人工智能和国防股票的目标价格大幅提升</li>
</ul>
<p><strong>想看看其他对 ZTS 持有的对冲基金吗？</strong> 请访问 HoldingsChannel.com 获取 Zoetis Inc. (NYSE:ZTS - 免费报告) 的最新 13F 文件和内部交易信息。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVpUUw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVpUUw"/></p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在 Zoetis 吗？</h2>
<p>在考虑 Zoetis 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前... 而 Zoetis 并不在名单上。</p>
<p>虽然 Zoetis 目前在分析师中被评为持有评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

硕腾

纳斯达克生物科技指数 ETF - iShares Nasdaq

生物科技 ETF - VanEck Vectors

<p>Coldstream Capital Management Inc. 将其在 Zoetis Inc. 的持股减少了 83.4%，在第四季度出售了 28,756 股，剩余 5,727 股，价值 721,000 美元。其他投资者也增加了他们的持股。Zoetis 报告第一季度每股收益为 1.53 美元，未达到预期，并宣布每股季度股息为 0.53 美元。分析师对该股票的评级各不相同，摩根大通将其目标价从 190 美元下调至 130 美元</p>

<p>Coldstream Capital Management Inc. lessened its stake in shares of Zoetis Inc. (NYSE:ZTS - Free Report) by 83.4% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 5,727 shares of the company's stock after selling 28,756 shares during the quarter. Coldstream Capital Management Inc.'s holdings in Zoetis were worth $721,000 as of its most recent filing with the SEC.</p>
<div class="lb-trans"><p>Coldstream Capital Management Inc. 在最近向美国证券交易委员会提交的 13F 文件中表示，在第四季度减少了对 Zoetis Inc.（纽约证券交易所代码：ZTS - 免费报告）股份的持有，减持幅度为 83.4%。该机构投资者在出售了 28,756 股后，持有该公司 5,727 股股票。根据其最近向美国证券交易委员会提交的文件，Coldstream Capital Management Inc. 在 Zoetis 的持股价值为 721,000 美元。</p>
</div><ul>
<li>Which Pet Stock Should Get Your Tail Wagging in 2024?</li>
</ul>
<div class="lb-trans"><ul>
<li>2024 年哪只宠物股票值得关注？</li>
</ul>
</div><p>Other large investors also recently made changes to their positions in the company. Global Wealth Strategies &amp; Associates bought a new stake in shares of Zoetis during the 4th quarter worth about $25,000. Lodestone Wealth Management LLC bought a new stake in Zoetis during the 4th quarter valued at approximately $30,000. KERR FINANCIAL PLANNING Corp bought a new stake in Zoetis during the 3rd quarter valued at approximately $31,000. Holos Integrated Wealth LLC bought a new stake in Zoetis during the 4th quarter valued at approximately $32,000. Finally, Elyxium Wealth LLC bought a new stake in Zoetis during the 4th quarter valued at approximately $32,000. Institutional investors own 92.80% of the company's stock.</p>
<div class="lb-trans"><p>其他大型投资者最近也对该公司的持仓进行了调整。Global Wealth Strategies &amp; Associates 在第四季度购买了价值约 25,000 美元的 Zoetis 新股份。Lodestone Wealth Management LLC 在第四季度购买了价值约 30,000 美元的 Zoetis 新股份。KERR FINANCIAL PLANNING Corp 在第三季度购买了价值约 31,000 美元的 Zoetis 新股份。Holos Integrated Wealth LLC 在第四季度购买了价值约 32,000 美元的 Zoetis 新股份。最后，Elyxium Wealth LLC 在第四季度购买了价值约 32,000 美元的 Zoetis 新股份。机构投资者目前持有该公司 92.80% 的股份。</p>
</div><h2>Insider Activity</h2>
<div class="lb-trans"><h2>内部活动</h2>
</div><p>In other news, Director Paul Bisaro acquired 2,000 shares of the stock in a transaction dated Wednesday, May 13th. The shares were acquired at an average cost of $75.88 per share, for a total transaction of $151,760.00. Following the completion of the transaction, the director owned 27,862 shares in the company, valued at approximately $2,114,168.56. This trade represents a 7.73% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Director Frank A. Damelio acquired 6,650 shares of the stock in a transaction dated Wednesday, May 13th. The shares were purchased at an average price of $75.39 per share, for a total transaction of $501,343.50. Following the completion of the transaction, the director owned 21,458 shares of the company's stock, valued at $1,617,718.62. This trade represents a 44.91% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Over the last ninety days, insiders have bought 11,650 shares of company stock worth $886,384. Company insiders own 0.22% of the company's stock.</p>
<div class="lb-trans"><p>在其他消息中，董事 Paul Bisaro 于 5 月 13 日星期三购买了 2,000 股该股票。每股平均成本为 75.88 美元，总交易额为 151,760.00 美元。交易完成后，该董事持有 27,862 股公司股票，价值约 2,114,168.56 美元。此交易代表其持仓增加了 7.73%。该交易已在美国证券交易委员会的法律文件中披露，相关信息可通过美国证券交易委员会网站获取。此外，董事 Frank A. Damelio 于 5 月 13 日星期三购买了 6,650 股该股票。每股购买价格为 75.39 美元，总交易额为 501,343.50 美元。交易完成后，该董事持有 21,458 股公司股票，价值 1,617,718.62 美元。此交易代表其持仓增加了 44.91%。有关此次购买的更多细节可在官方的美国证券交易委员会披露中找到。在过去的九十天里，内部人士购买了价值 886,384 美元的 11,650 股公司股票。公司内部人士持有该公司 0.22% 的股份。</p>
</div><h2>Zoetis Stock Performance</h2>
<div class="lb-trans"><h2>Zoetis 股票表现</h2>
</div><ul>
<li>MarketBeat Week in Review – 07/31 - 08/04</li>
</ul>
<div class="lb-trans"><ul>
<li>MarketBeat 周回顾 – 07/31 - 08/04</li>
</ul>
</div><p>ZTS opened at $79.48 on Thursday. The stock has a market cap of $33.32 billion, a PE ratio of 13.18, a P/E/G ratio of 1.31 and a beta of 0.87. The company has a current ratio of 3.15, a quick ratio of 1.91 and a debt-to-equity ratio of 2.80. Zoetis Inc. has a 1 year low of $72.38 and a 1 year high of $172.23. The stock's 50 day simple moving average is $105.95 and its 200-day simple moving average is $117.60.</p>
<div class="lb-trans"><p>周四，ZTS 的开盘价为 79.48 美元。该股票的市值为 333.2 亿美元，市盈率为 13.18，市盈增长比率为 1.31，贝塔值为 0.87。该公司的流动比率为 3.15，速动比率为 1.91，债务与股本比率为 2.80。Zoetis Inc. 的一年低点为 72.38 美元，一年高点为 172.23 美元。该股票的 50 日简单移动平均为 105.95 美元，200 日简单移动平均为 117.60 美元。</p>
</div><p>Zoetis (NYSE:ZTS - Get Free Report) last released its quarterly earnings data on Thursday, May 7th. The company reported $1.53 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.60 by ($0.07). The firm had revenue of $2.26 billion for the quarter, compared to the consensus estimate of $2.30 billion. Zoetis had a net margin of 27.80% and a return on equity of 66.85%. The business's revenue for the quarter was up 2.9% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.48 earnings per share. Zoetis has set its FY 2026 guidance at 6.850-7.000 EPS. Sell-side analysts forecast that Zoetis Inc. will post 6.88 EPS for the current year.</p>
<div class="lb-trans"><p>Zoetis（纽约证券交易所代码：ZTS - 获取免费报告）最近于 5 月 7 日星期四发布了季度财报。该公司报告的每股收益（EPS）为 1.53 美元，低于分析师一致预期的 1.60 美元，差距为 0.07 美元。该公司季度收入为 22.6 亿美元，而一致预期为 23 亿美元。Zoetis 的净利润率为 27.80%，股本回报率为 66.85%。该公司季度收入同比增长 2.9%。在去年同期，该公司每股收益为 1.48 美元。Zoetis 已将其 2026 财年的指导目标设定为 6.850-7.000 每股收益。卖方分析师预测 Zoetis Inc. 本年度将发布 6.88 每股收益。</p>
</div><h2>Zoetis Announces Dividend</h2>
<div class="lb-trans"><h2>Zoetis 宣布分红</h2>
</div><ul>
<li>Rising Dividend Make Zoetis a Doggone Winner</li>
</ul>
<div class="lb-trans"><ul>
<li>不断上升的分红使 Zoetis 成为赢家</li>
</ul>
</div><p>The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 1st. Stockholders of record on Monday, July 20th will be given a dividend of $0.53 per share. The ex-dividend date is Monday, July 20th. This represents a $2.12 dividend on an annualized basis and a dividend yield of 2.7%. Zoetis's payout ratio is currently 35.16%.</p>
<div class="lb-trans"><p>该公司最近还披露了季度分红，将于 9 月 1 日星期二支付。7 月 20 日星期一的股东将获得每股 0.53 美元的分红。除息日期为 7 月 20 日星期一。这相当于每年 2.12 美元的分红，分红收益率为 2.7%。Zoetis 的派息比率目前为 35.16%。</p>
</div><h2>Analyst Ratings Changes</h2>
<div class="lb-trans"><h2>分析师评级变动</h2>
</div><p>Several brokerages recently weighed in on ZTS. JPMorgan Chase &amp; Co. decreased their target price on Zoetis from $190.00 to $130.00 and set an &#34;overweight&#34; rating for the company in a research note on Friday, May 8th. Argus restated a &#34;hold&#34; rating on shares of Zoetis in a research note on Wednesday. Weiss Ratings downgraded Zoetis from a &#34;hold (c-)&#34; rating to a &#34;sell (d+)&#34; rating in a research note on Friday, March 27th. Wall Street Zen downgraded Zoetis from a &#34;buy&#34; rating to a &#34;hold&#34; rating in a research note on Saturday, May 2nd. Finally, Bank of America increased their target price on Zoetis from $135.00 to $140.00 and gave the company a &#34;neutral&#34; rating in a research note on Friday, February 13th. Six analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the company's stock. According to MarketBeat, Zoetis presently has an average rating of &#34;Hold&#34; and an average price target of $133.92.</p>
<div class="lb-trans"><p>几家券商最近对 ZTS 进行了评估。摩根大通将 Zoetis 的目标价从 190.00 美元下调至 130.00 美元，并在 5 月 8 日的研究报告中给予该公司 “增持” 评级。Argus 在周三的研究报告中重申了对 Zoetis 股票的 “持有” 评级。Weiss Ratings 将 Zoetis 的评级从 “持有（c-）” 下调至 “卖出（d+）”，该评级在 3 月 27 日的研究报告中发布。Wall Street Zen 在 5 月 2 日的研究报告中将 Zoetis 的评级从 “买入” 下调至 “持有”。最后，美国银行在 2 月 13 日的研究报告中将 Zoetis 的目标价从 135.00 美元上调至 140.00 美元，并给予该公司 “中性” 评级。六位分析师对该股票给予了买入评级，八位分析师给予了持有评级，一位分析师给予了卖出评级。根据 MarketBeat，Zoetis 目前的平均评级为 “持有”，平均目标价为 133.92 美元。</p>
</div><p><strong>Read Our Latest Report on ZTS</strong></p>
<div class="lb-trans"><p><strong>阅读我们关于 ZTS 的最新报告</strong></p>
</div><h2>Zoetis Profile</h2>
<div class="lb-trans"><h2>Zoetis 公司简介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免费报告）</p>
</div><p>Zoetis Inc NYSE: ZTS is a global animal health company that develops, manufactures and markets a broad portfolio of products and services for companion animals and livestock. The company's offerings include pharmaceuticals, vaccines and biologics, parasiticides and anti-infectives, as well as diagnostic instruments, consumables and laboratory testing services. Zoetis serves the veterinary community, livestock producers and other animal-health customers with products designed to prevent, detect and treat disease and to support animal productivity and welfare.</p>
<div class="lb-trans"><p>Zoetis Inc.（纽约证券交易所代码：ZTS）是一家全球动物健康公司，开发、生产和销售广泛的宠物和牲畜产品及服务。该公司的产品包括药品、疫苗和生物制品、驱虫剂和抗感染药物，以及诊断仪器、耗材和实验室检测服务。Zoetis 为兽医社区、牲畜生产者和其他动物健康客户提供旨在预防、检测和治疗疾病的产品，以支持动物的生产力和福利。</p>
</div><p>Zoetis traces its roots to the animal health business of Pfizer and became an independent, publicly traded company following a 2013 separation and initial public offering.</p>
<div class="lb-trans"><p>Zoetis 的根源可以追溯到辉瑞的动物健康业务，并在 2013 年分拆和首次公开募股后成为一家独立的上市公司。</p>
</div><h2>Recommended Stories</h2>
<div class="lb-trans"><h2>推荐故事</h2>
</div><ul>
<li>Five stocks we like better than Zoetis</li>
<li>Abercrombie Rallies as Strong Q1 Earnings Extend Winning Streak</li>
<li>TeraWulf Bets on Power Infrastructure to Lead AI Build-Out</li>
<li>Amazon's Alexa for Shopping Strengthens an Already Strong Bull Case</li>
<li>Keysight: The AI and Defense Stock Seeing Big Price Target Boosts</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们认为比 Zoetis 更好的股票</li>
<li>Abercrombie 强劲的第一季度财报延续了胜利的势头</li>
<li>TeraWulf 投资电力基础设施以引领人工智能建设</li>
<li>亚马逊的 Alexa 购物功能增强了已经强劲的牛市论点</li>
<li>Keysight：人工智能和国防股票的目标价格大幅提升</li>
</ul>
</div><p><strong>Want to see what other hedge funds are holding ZTS?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zoetis Inc. (NYSE:ZTS - Free Report).</p>
<div class="lb-trans"><p><strong>想看看其他对 ZTS 持有的对冲基金吗？</strong> 请访问 HoldingsChannel.com 获取 Zoetis Inc. (NYSE:ZTS - 免费报告) 的最新 13F 文件和内部交易信息。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVpUUw" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=ZTS"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Zoetis Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 Zoetis 吗？</h2>
</div><p>Before you consider Zoetis, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 Zoetis 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Zoetis wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前... 而 Zoetis 并不在名单上。</p>
</div><p>While Zoetis currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Zoetis 目前在分析师中被评为持有评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Coldstream Capital Management Inc. Sells 28,756 Shares of Zoetis Inc. $ZTS

Market Beat

美国制药 ETF - iShares

医药突破 ETF - ALPS

基因改革 ETF - ARK

标普全球医疗股指数 ETF - iShares

标普生物技术 ETF - SPDR

纽交所高增长板生物技术指数 ETF - First Trust

标普生物技术 3 倍做多 - Direxion

动态生物技术与基因组 ETF - Invesco

医疗业 ETF - Vanguard

Invesco Nasdaq Biotechnology ETF

医疗业 ETF - SPDR

摩根大通

美国银行

JPMORGAN CHASE & CO. 4.20% DEP SHS REPSTG 1/400TH PFD SER MM

JPMORGAN CHASE & CO. 6%NON CUM DEP SHS REP 1/400TH PFD SER EE

JPMORGAN CHASE & CO. DEP REP 1/400TH (5.75% NON CUM PFD DD)

JPMORGAN CHASE & CO. 4.625% DEP SH RE 1/400TH INT NO CU PF LL

JPMorgan Chase & Co.

JPMORGAN CHASE & CO. 4.55% DEP SHS REPSTG 1/400TH PFD SER JJ

JPMORGAN CHASE & CO. 4.75 DEP SHS REP 1/400 NCUM PFD SR GG

BANK OF AMERICA CORPORATION DEP SHS REP 1/1000TH INT NON CUM PFD QQ

BANK OF AMERICA CORPORATION DEP SHS REP 1/1200TH PRF SERIES '5'

BANK OF AMERICA CORPORATION 7.25% NON-CUM PERP CONV PFD SER L

BANK OF AMERICA CORPORATION 5.875%NON CUM DEP SHS REP1/1000TH SER HH

BANK OF AMERICA CORPORATION DEP SHS REP 1/1200TH PRF SERIES '2'

BANK OF AMERICA CORPORATION 5% DEP SHS REPR 1/1000TH NON CUM PFD LL

BANK OF AMERICA CORPORATION DEP SHARES REP 1/1000TH PERP PFD SER 'E'

BANK OF AMERICA CORPORATION INCOME CAPITAL OBLIG NTS DUE 15/12/2066

BANK OF AMERICA CORPORATION 4.375% DP SH RP 1/1000TH IN NON CU PF NN

BANK OF AMERICA CORPORATION DEP SH REP 1/1200TH PRF SER 1 USD25

BANK OF AMERICA CORPORATION 5.375%DEP SHS REP 1/1000TH NON CUM SR KK

BANK OF AMERICA CORPORATION 6%NON CUM DEP SHS EACH REP 1/1000 SER GG

BANK OF AMERICA CORPORATION DEP SHS REP 1/1200 PFD SER 4 USD25

BANK OF AMERICA CORPORATION DEP SHS REP 1/1000TH NON CUM PFD SER SS

BANK OF AMERICA CORPORATION 4.125%DEP SH REP 1/1000 PFD SER PP USD25

Bank of America Corp

Coldstream Capital Management Inc.出售了 28,756 股硕腾公司（Zoetis Inc.）的股票，股票代码为$ZTS